Hereditary angioedema patients would prefer newer-generation oral prophylaxis.
Daniela GebaJohan Mohd SaniMichaela GasconRebecca HahnKavita AggarwalJinky Rosselli
Published in: Journal of drug assessment (2021)
Most patients with HAE would prefer a newer generation oral prophylactic medication that would decrease treatment burden and allow them to live fuller lives.